Contract facts
FederalEDISCOVERY PLATFORM FOR DOCUMENT REVIEW is a federal award for Fda Office Of Acq Grant Svcs held by Aurotech, Inc. Estimated value $401K ($-1,082,837.44 obligated). Current period of performance ends Apr 11, 2022. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.
Recompete timing
PublicCurrent PoP ended Apr 11, 2022 (1593 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAurotech, Inc — $11.1M obligated across 26 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40121F80103?
75F40121F80103 (Ediscovery platform for document REVIEW) is a Fda Office Of Acq Grant Svcs award with a potential value of $401K, currently held by Aurotech, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40121F80103?
Fda Office Of Acq Grant Svcs awarded 75F40121F80103 to Aurotech, Inc (potential $401K).
Who is the incumbent on 75F40121F80103?
Aurotech, Inc is the incumbent with $11.1M across 26 related awards in SCOUT’s public footprint. The current period of performance ends Apr 11, 2022.
When does Aurotech, Inc’s 75F40121F80103 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 11, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
